Apic Bio
Cambridge · Founded 2017
About Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases. The company is advancing several novel gene therapies to treat Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic Amyotrophic Lateral Sclerosis (ALS), and other CNS diseases.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $53.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2019)
- Website: apic-bio.com
- Phone: (857) 302-3757
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/apic-bio-1838 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.